Cyberkinetics Neurotechnology Systems, Inc. Product Pipeline Analysis

SUMMARY

Cyberkinetics Neurotechnology Systems, Inc. Product Pipeline Analysis

Summary

This report is an insightful source for data, analysis and strategic insights into a Cyberkinetics Neurotechnology Systems, Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

• Details of development stage by sector and equipment type.
• Pipeline products grouped by therapy area, development stage and trial phase.
• Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
• Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
• Product updates covering estimated approval dates and estimated launch dates.
• Descriptions of novel technologies relating to pipeline products of the company.
• Patents and patent applications covered for the product.
• News updates on key events relating to the product and its development.

Reasons to buy

• A single source to fulfill competitor information relating to products in development.
• Identify pipeline products that are potential competitor to your product lines.
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
• Access clinical trial information to map trial results and plan targeted marketing activities.
• Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
• Identification of potential investment opportunities.
• Build up knowledge base for potential distribution and marketing partners.
• Helps avoid patent infringement.
• Timelines from concept to market lets you keep track of market potential build for a new product.
Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

TABLE OF CONTENTS

1 Table of Contents 3
1.1 List of Tables 6
1.2 List of Figures 7
2 Company Snapshot 8
2.1 Key Information 8
2.2 Company Overview 8
3 Business Description 9
3.1 Business Overview 9
3.2 Major Products and Services 9
3.2.1 Overview 9
4 History 11
5 Competitors 12
6 Key Employees 13
7 Key Employee Biographies 14
8 Company Statement 17
9 Locations And Subsidiaries 19
9.1 Head Office 19
9.2 Other Locations & Subsidiaries 19
10 Recent Developments 20
10.1 Financial Announcements 20
10.1.1 Nov 14, 2007: Cyberkinetics Declares Q3 2007 Results 20
10.1.2 Aug 09, 2007: Cyberkinetics Reports Q2 2007 Results 21
10.1.3 May 10, 2007: Cyberkinetics Reports Q1 2007 Results 21
10.1.4 Dec 31, 2006: Cyberkinetics Reports Q4 2006 Results 22
10.1.5 Nov 08, 2006: Cyberkinetics Reports Q3 2006 Results 23
10.2 Corporate Communications 23
10.2.1 Sep 19, 2006: Cyberkinetics Appoints New CFO 23
10.3 Product News 23
10.3.1 Mar 03, 2008: Cyberkinetics Andara OFS Therapy Featured In Presentations at the AANS/CNS Meeting 23
10.3.2 Dec 11, 2007: Cyberkinetics Receives FDA Response Letter On Andara OFS System For Acute Spinal Cord Injury 24
10.3.3 Apr 11, 2007: United States Patent And Trademark Office Issues Cyberkinetics Patent For Andara OFS Therapy 24
10.3.4 Feb 20, 2007: Cyberkinetics Files To Market Andara OFS Therapy For Acute Spinal Cord Injury Under Humanitarian Device Exemption 24
11 Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products 25
11.1 Cyberkinetics Neurotechnology Systems, Inc. Product Pipeline Analysis 25
11.1.1 Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By Equipment Type 25
11.1.2 Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By Development Stage 26
11.1.3 Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By Therapy Area 27
11.1.4 Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By Clinical Trials 27
11.1.5 Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By News Summary 28
11.2 Andara Oscillating Field Stimulator system 28
11.2.1 Product Description 29
11.2.2 Product Status 29
11.2.3 Clinical Trials 29
11.2.4 Product Milestone 29
11.3 Andara OFS Plus 30
11.3.1 Product Description 30
11.3.2 Product Status 30
11.4 BrainGate Neural Interface System 31
11.4.1 Product Description 31
11.4.2 Product Status 31
11.4.3 Clinical Trials 31
12 Appendix 33
12.1 Methodology 33
12.1.1 Coverage 33
12.1.2 Secondary Research 34
12.1.3 Primary Research 34
12.1.4 Expert Panel Validation 35
12.2 Contact Us 35
12.3 About Global Markets Direct 35
12.4 Disclaimer 35

1.1 List of Tables
Table 1: Cyberkinetics Neurotechnology Systems, Inc.,Key Facts 8
Table 2: Cyberkinetics Neurotechnology Systems, Inc., Key Employees, 13
Table 3: Cyberkinetics Neurotechnology Systems, Inc., Other Locations 19
Table 4: Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products by Equipment Type 25
Table 5: Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By Development Stage 26
Table 6: Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By Therapy Area 27
Table 7: Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By Clinical Trials 27
Table 8: Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By News Summaries 28

1.2 List of Figures
Figure 1: Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By Development Stage 26
Figure 2: Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By News Summary 28
Figure 3: Global Markets Direct Methodology 33